PLPia Rengtved Lundegaard

Pia Rengtved Lundegaard

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Pia Rengtved Lundegaard has a total of 444 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Plasma proteomics enhances genetic risk prediction and biological understanding of venous thromboembolism

    by Yingyi Mei, Oliver Bundgaard Vad, Astrid Filt Beyer, Jonas Ghouse, Pia Rengtved Lundegaard

  • Open Access

    Prevalence of deleterious variants in cardiomyopathy genes in early-onset atrial fibrillation

    by Oliver Bundgaard Vad, Quim Bech Vilaseca, Astrid Filt Beyer, Christian Paludan-Müller, Laura Andreasen, Jesper Hastrup Svendsen, Pia Rengtved Lundegaard

    Atrial fibrillation (AF) is a common cardiac arrhythmia associated with an increased risk of stroke, heart failure, and death. Recent studies suggest that early-onset AF increases the risk of developing heart failure and dilated cardiomyopathy. This study aimed to identify genetic variants in a large set of 34 cardiomyopathy genes among early-onset AF individuals. We conducted targeted sequencing of cardiomyopathy-associated genes in 478 individuals from a Danish cohort with early AF onset. Additionally, we analyzed whole exome sequencing data from 375,869 individuals from the UK Biobank, including 29,267 individuals with AF. Of the Danish individuals with early-onset AF, 8.8% carried pathogenic or likely pathogenic (P/LP) variants in cardiomyopathy-associated genes. The prevalence of rare P/LP variants in the UK Biobank analysis ranged from 3.85% in the group with early AF onset to 1.03% in the group without AF diagnosis. Results were largely consistent when excluding individuals with no prior cardiomyopathy or heart failure diagnosis. This suggests that genetic testing for cardiomyopathy could be relevant in selected individuals with early AF diagnosis.


  • Open Access

    Pooling cohorts for deep learning analysis: a potential source of bias for electrocardiogram analysis

    by Marie Mørch-Pedersen, Malene Nørregaard, Claus Graff, Oliver B. Vad, Pia R. Lundegaard, Jesper Hastrup Svendsen, Torben Hansen, Allan Linneberg, Peter G. Jørgensen, Magnus T. Jensen, et al.


  • Open Access

    Plasma proteomic signature of the human menstrual cycle

    by Iben Riishede, Line Rode, Pia Rengtved Lundegaard, Søren Albertsen Rand, Lars Dyrskjøt, Ole Halfdan Larsen, Charlotte Kvist Ekelund, Anja Pinborg, Stefan Stender, Jonas Ghouse

    The menstrual cycle is one of the most fundamental biological rhythms in human physiology, yet its systemic molecular changes remain poorly understood. Here we show that the menstrual cycle is accompanied by widespread changes in the circulating proteome. By profiling nearly 3,000 plasma proteins in 2,760 women from the UK Biobank, we identified 198 proteins that vary across the cycle, forming distinct temporal patterns aligned with menstrual phases. These proteins include reproductive hormones, cytokines and growth factors, many of which are enriched in endometrial tissue and expressed in epithelial and stromal cell types, highlighting their biological specificity. Several proteins were linked to common reproductive disorders, including endometriosis, leiomyoma and abnormal bleeding. Finally, we developed a proteomic score on the basis of 75 proteins that accurately predicts menstrual cycle phase. Together, these findings provide a systems-level atlas of menstrual cycle biology and inform biomarker discovery in women’s health.


  • Association between IL-6 and hs-CRP and cardiovascular risk in clinically relevant subgroups

    by Johan Skov Bundgaard, Gustav Ahlberg, Søren Albertsen Rand, Pia Rengtved Lundegaard, Stefan Stender, Bjarni J Vilhjálmsson, Kathrine Agergård Kaspersen, Ole Halfdan Larsen, Ruth Frikke Schmidt, Henning Bundgaard, et al.


  • Open Access

    Prevalence of deleterious variants in cardiomyopathy genes in early-onset atrial fibrillation

    by Pia Lundegaard, Oliver Vad, Quim Vilaseca, Astrid Beyer, Christian Paludan-Müller, Laura Andreasen, Jesper Svendsen

    Atrial fibrillation (AF) is a common cardiac arrhythmia associated with an increased risk of stroke, heart failure, and death. Recent studies suggest that early-onset AF increases the risk of developing heart failure and dilated cardiomyopathy. This study aims to identify genetic variants in a large set of cardiomyopathy genes among early-onset AF individuals. We conducted targeted sequencing of 29 cardiomyopathy-associated genes in 478 individuals from a Danish cohort with early AF onset. Additionally, we analyzed whole exome sequencing data from 374,289 individuals from the UK Biobank, including 29,108 individuals with AF. 8.8% of the Danish individuals with early-onset AF carry truncating variants in cardiomyopathy-associated genes. The prevalence of truncating variants in the UK Biobank analysis ranges from 3.8% in the group with early AF onset to 1.4% in the group without AF diagnosis. This suggests that genetic testing for cardiomyopathy could be relevant in selected individuals with early AF diagnosis.

  • Open Access

    Plasma proteomics enhances genetic risk prediction and biological understanding of venous thromboembolism

    by Yingyi Mei, Oliver Bundgaard Vad, Astrid Filt Beyer, Jonas Ghouse, Pia Rengtved Lundegaard

    Venous thromboembolism (VTE) involves complex genetic and molecular interactions not fully captured by current prediction tools. This study integrated a polygenic risk score (PRS) with plasma proteomics data from 44,138 UK Biobank participants to explore the molecular mechanisms underlying VTE. Associations between PRS VTE and 2,911 plasma proteins were analyzed, identifying 265 significant proteins linked to extracellular matrix organization and transmembrane signaling activity. Cox regressions further identified 354 proteins that significantly associated with incident VTE. Mendelian randomization supported causal relationships for 13 proteins, indicating their potential as therapeutic targets. To improve clinical risk prediction, we developed a protein-based risk score (ProteinRS) using LASSO regression. Here we show that the ProteinRS significantly improves VTE discrimination beyond traditional clinical factors and revealed a three-fold gradient in cumulative VTE risk (Hazard Ratio 0.52 vs 1.49). Our findings demonstrate that integrating plasma proteomics with genetic risk scores provides valuable biological insights and improves prediction of VTE.


  • Open Access

    Genome-wide meta-analysis identifies nine loci associated with higher risk of hepatocellular carcinoma development

    by Jonas Ghouse, Helene Gellert-Kristensen, Colm J. O’rOurke, Anne-Sofie Seidelin, Gudmar Thorleifsson, Gardar Sveinbjörnsson, Vinicius Tragante, Chigoziri Konkwo, Joseph Brancale, Silvia Vilarinho, et al.


  • Gain-of-function enhancer variant near KCNB1 causes familial ST-depression syndrome

    by Alex Hørby Christensen, Gang Pan, Rasmus L Marvig, Francisco German Rodriguez Gonzalez, Christoffer Rasmus Vissing, Elvira Silajdzija, Rasmus Frosted, Etsehiwot Girum Girma, Migle Gabrielaite, Henrik Kjærulf Jensen, et al.

    Background and Aims: Familial ST-depression syndrome (FSTD) is a recently identified inherited cardiac disease associated with arrhythmias and systolic dysfunction. The underlying genetic aetiology has remained elusive. This study aimed at finding the causative variant. Methods: A total of 67 FSTD patients (20 families) were studied. Linkage analysis and whole-genome sequencing (WGS) were initially performed. An identified non-coding variant was functionally characterized in AC16 human cardiomyocytes, muscle tissue, and human myocardium. In silico analyses, luciferase and dCas9-activator/repressor assays, protein–DNA experiments, chromosome conformation capture (4C), and RNA sequencing were also performed. Results: The electrocardiographic (ECG) phenotype was inherited in an autosomal dominant manner in all families. Linkage analysis revealed a single peak on chromosome 20, and WGS identified a single, rare, non-coding variant located 18 kb downstream of KCNB1 on chromosome 20 in all affected individuals. Perfect co-segregation with the ECG phenotype was observed together with full penetrance in all families. The variant creates a MEF2-binding site and presence of the variant allele or MEF2 co-expression enhanced transcriptional activity. dCas9-activator/repressor assays showed that KCNB1 was the only gene consistently regulated by the locus and 4C experiments in AC16 cells and human muscle tissue confirmed the locus–KCNB1 promoter interaction. Expression analysis in human endocardial tissue did not document any change in gene expression likely explained by expressional heterogeneity. Conclusions: A gain-of-function enhancer variant creates a hyperactive regulatory locus that interacts with the KCNB1 promoter and causes FSTD. This is the first time that KCNB1 has been implicated in human cardiac electrophysiology and arrhythmogenesis.


  • Open Access

    Prevalence of deleterious cardiomyopathy variants in early-onset atrial fibrillation

    by Quim Bech Vilaseca, Oliver Bundgaard Vad, Christian Paludan-Müller, Laura Andreasen, Morten Salling Olesen, Jesper Hastrup Svendsen, Pia Rengtved Lundegaard

    Background: Atrial fibrillation (AF) is a common cardiac arrhythmia associated with an increased risk of stroke, heart failure, and death. Recent studies suggests that individuals with early onset of AF could be at increased risk of developing heart failure and dilated cardiomyopathy. This study aimed to identifying genetic variants in a broad panel of cardiomyopathy genes among early-onset AF individuals. Methods: We conducted targeted genetic sequencing of 29 cardiomyopathy-associated genes in 478 individuals with AF onset below 45 years of age from a Danish cohort. Additionally, we analyzed whole exome sequencing data in 374,289 individuals from the UK Biobank, including 29,108 individuals with AF. The cohort was stratified by age at AF diagnosis, and individuals with pre-existing cardiomyopathy were excluded. We focused on rare, truncating variants predicted to lead to loss of function, and potentially deleterious missense variants in the UK Biobank. Results: In the Danish cohort, 42 (8.8%) individuals with early-onset AF had truncating genetic variants in known cardiomyopathy genes. The UK Biobank analysis showed an inverse dose-response-like relationship between age of AF onset and prevalence of truncating variants, ranging from 3.8% in the AF onset <45 years group to 1.4% in the group without AF diagnosis. The prevalence of rare missense variants showed a similar pattern. Conclusions: We identified a high prevalence of deleterious variants in cardiomyopathy-associated genes among individuals with early-onset AF. This supports recent guideline suggestions and indicates that genetic testing and surveillance for cardiomyopathy could be relevant in selected individuals with an early AF diagnosis.